Mobile

A multicentre, double-blind, randomised, parallel group, placebo-controlled trial of LAX-101 (ethyl eicosapentaenoate [EPA]) as adjunct therapy in patients who remain depressed following treatment wit...

Mise à jour : Il y a 4 ans
Référence : ISRCTN38354847

A multicentre, double-blind, randomised, parallel group, placebo-controlled trial of LAX-101 (ethyl eicosapentaenoate [EPA]) as adjunct therapy in patients who remain depressed following treatment with standard antidepressant therapy

Femme et Homme

Extrait

Not provided at time of registration

Critère d'inclusion

  • depression

Liens